Mid-Term Performance of Clinical LINAC in Volumetric Modulated Arc Therapy

  • Received : 2019.02.20
  • Accepted : 2019.02.28
  • Published : 2019.03.31


Background: The mid-term performance of clinical linear accelerator (LINAC) during volumetric modulated arc therapy (VMAT) treatment period is not performed in clinical practice and usually replaced with one-time plan quality assurance (QA). In this research we aim to monitor daily reproducibility of VMAT delivery from tracking individual leaf movement error and dosimetric error to evaluate the mid-term quality of the machine used. Materials and Methods: First, multileaf collimator (MLC) information was imported into MATLAB program to determine which of the MLC leaves in the leaf bank had the maximum RMS position error (maxRMS). We estimated where the maximum positional errors (maxPE) of the chosen leaf occur along its path length and tracked its daily variations over the entire treatment period. Secondly, picture information of dosimetric error from portal dosimetry was imported into MATLAB where representative high gamma index region (HGR) was determined as HGR with length of > 1 cm and their centers were daily tracked. Results and Discussion: The maxPEs in the brain and tongue cases were distributed broader than in other cases, but all data were found located within ${\pm}0.5mm$. From first day to last day all of five cases show the similar visual pattern of HGRs and Centers of the longest HGRs remained within ${\pm}1mm$ of that in first day. These findings prove excellent mid-term performance of the LINAC used in VMAT treatments over a full course of treatment. Conclusion: Tracking the daily location changes of leaf movement and dosimetric error can be a good indicator of predicting the daily quality like stability and reproducibility of beam delivering in VMAT treatment.


Supported by : Korea Foundation Of Nuclear Safety (KoFONS)


  1. Bruggeman DJ, Hernandez V, Saez J, Navarro D, Pino F, Martinez T, Alayrach ME, Ailleres N, Melero A, Jornet N. Multi-centre audit of VMAT planning and pre-treatment verification. Radiother. Oncol. 2017;124:302-310.
  2. Liang B, Liu B, Zhou F, Yin F, Wu Q. Comparisons of volumetric modulated arc therapy (VMAT) quality assurance (QA) systems: sensitivity analysis to machine errors. Radiat. Oncol. 2016;11:146.
  3. Sjolin M, Edmund JM. Incorrect dosimetric leaf separation in IMRT and VMAT treatment planning: Clinical impact and correlation with pretreatment quality assurance. Phys. Medica. 2016; 32:918-925.
  4. Paslera M, Kaas J, Perik T, Geuze J, Dreindl R, Künzler T, Wittkamper F, Georg D. Linking log files with dosimetric accuracy - A multi-institutional study on quality assurance of volumetric modulated arc therapy. R. Radiother. Oncol. 2015;117:407-411.
  5. Nithiyanantham K, Mani GK, Subramani V, Mueller L, Palaniappan KK, Kataria T. Analysis of direct clinical consequences of MLC positional errors in volumetric-modulated arc therapy using 3D dosimetry system. J. Appl. Clin. Med. Phys. 2015;16(5):296-305.
  6. Hussein M, Rowshanfarzad P, Ebert MA, Nisbet A, Clark CH. A comparison of the gamma index analysis in various commercial IMRT/VMAT QA systems. Radiother. Oncol. 2013;109:370-376.
  7. Heilemann G, Poppe B, Laub W. On the sensitivity of common gamma-index evaluation methods to MLC misalignments in Rapidarc quality assurance. Med. Phys. 2013;40(3):031702/1-12.
  8. Fredh A, Bengtsson J, Rosenschold PM. Patient QA systems for rotational radiation therapy: A comparative experimental study with intentional errors. Med. Phys. 2013;40(3):031716/1-9.
  9. Tatsumi D, Hosono MN, Nakada R, Ishii K, Tsutsumi S, Inoue M, Ichida T, Miki Y. Direct impact analysis of multi-leaf collimator leaf position errors on dose distributions in volumetric modulated arc therapy: a pass rate calculation between measured planar doses with and without the position errors. Phys. Med. Biol. 2011;56:N237-N246.
  10. LoSasso T. IMRT Delivery Performance with a Varian Multileaf Collimator. Int. J. Radiation Oncology Biol. Phys. 2008;71(1):S85-S88.
  11. Park H, Choi HJ, Kim JI, Min CH. Analysis of dose distribution according to the initial electron beam of the linear accelerator: A Monte Carlo Study. J. Radiat. Prot. Res. 2018;43(1):10-19.
  12. Kerns JR, Stingo F, Followill DS, Howell RM, Melancon A, Kry SF. Treatment planning system calculation errors are present in most imaging and radiation oncology core-houston phantom failures. Int. J. Radiat. Oncol. Biol. Phys. 2017;98(5):1197-1203.
  13. Budgell GJ, Perrin BA, Mott JHL, Fairfoul J, Mackay RI. Quantitative analysis of patient-specific dosimetric IMRT verification. Phys. Med. Biol. 2005;50:103-119.
  14. Nathan L. Childress NL, White RA, Bloch C, Salehpour M, Dong L, Rosen II. Retrospective analysis of 2D patient-specific IMRT verifications. Med. Phys. 2005;32(4):838-850.
  15. Oh Y, Kim DW, Shin DO, Koo J, Lee SS, Choi SH, Ahn S, Park DW. Comparative analysis of terminology and classification related to risk management of radiotherapy. Prog. Med. Phys. 2016;27(3):131-138.
  16. Eric EK, et al. Task Group 142 report: Quality assurance of medical accelerators. Med. Phys. 2009;36(9):4197-4212.
  17. Smith K, Balter P, Duhon J, White GA Jr, Vassy DL Jr, Miller RA, Serago CF, Fairobent LA. AAPM Medical Physics Practice Guideline 8.a.: Linear accelerator performance tests. J. Appl. Clin. Med. Phys. 2017;18(4):23-39.
  18. Nederlandse Commisssie Voor Stralingsdosimetrie. Code of Practice for the Quality Assurance and Control for Volumetric Modulated Arc Therapy, Report 24 of the Netherlands Commission on Radiation Dosimetry. 2015:9-59.
  19. Agnew A, Agnew CE, Grattan MWD, Hounsell AR, McGarry CK. Monitoring daily MLC positional errors using trajectory log files and EPID measurements for IMRT and VMAT deliveries. Phys. Med. Biol. 2014;59:N49.
  20. Rahman MM, Kim CH, Kim S. Daily based quality assurance of volumetric modulated arc therapy for the full session of treatment. J. Korean. Phys. Soc. 2018;73(7):990-1000.
  21. Maraghechi B, Davis J, Badu S, Fleck A, Darko J, Osei E. Retrospective analysis of portal dosimetry pre-treatment quality assurance of prostate volumetric-modulated arc therapy (VMAT) plans. J. Radiother. Pract. 2018;17:44-52.
  22. Scaggion A, Negri A, Rossato MA, Roggio A, Simonato F, Bacco S, Paiusco M. Delivering RapidArc$^{(R)}$: A comprehensive study on accuracy and long term stability. Phys. Medica. 2016;32:866-873.
  23. Choi SH, Park D, Kim KB, Kim DW, Lee J, Shin DO. Suggestion for comprehensive quality assurance of medical linear accelerator in Korea. Prog. Med. Phys. 2015;26(4):294-303.
  24. Dynalog File Viewer Reference Guide (P/N 100013698-05). Varian Medical Systems, Palo Alto, CA, USA, January 2011.
  25. Riddle WR, Pickens DR. Extracting data from a DICOM file. Med. Phys. 2005;32(6):1537-1541.
  26. Portal Dosimetry Reference Guide (P1015288-001-A). Varian Medical Systems, Palo Alto, CA, USA, 2015.
  27. Ezzell GA, et al. IMRT commissioning: Multiple institution planning and dosimetry comparisons, a report from AAPM Task Group 119. Med. Phys. 2009;36(11):5359-5373.
  28. Otto K. Volumetric modulated arc therapy: IMRT in a single gantry arc. Med. Phys. 2008;35(1):310-317.
  29. Eclipse Photon and Electron Algorithms Reference Guide (P1008611‐003‐C). Varian Medical Systems, Palo Alto, CA, USA, January 2015.
  30. Sievinen J, Ulmer W, Kaissl W. AAA Photon Dose Calculation Model in EclipseTM. Janne Sievinen RAD #7170A.
  31. Esch AV, Depuydt T, Huyskens DP. The use of an aSi-based EPID for routine absolute dosimetric pre-treatment verification of dynamic IMRT fields. Radiother. Oncol. 2004;71:223-234.